IONS: Underwent a brutal sell off from its highs in Mar 2015 at $77.80 to a low of $19.59 in May 2016. A stock which underwent sell off of 75% warrants a look by bargain hunters. IONS partnership with BIIB just obtained EU approval for a 125K/treatment for spinal disease. This will inevidentably be just the antidote that IONS needs to return to its new highs and more. A break below Minute Wave ii will require adjustment of the wave counts.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.